Intelligent Vitamin D3 Delivery Systems
Legal Citation
Summary of the Inventive Concept
The present inventive concept integrates oral dissolvable films containing vitamin D3 with advanced technologies such as AI, IoT, blockchain, and novel materials to create personalized, secure, and efficient vitamin D3 delivery systems.
Background and Problem Solved
The original patent disclosed an oral dissolvable film containing vitamin D3, but it had limitations in terms of dosage control, tracking, and authentication. The new inventive concept addresses these limitations by combining the oral dissolvable film with synergistic technologies to create a more powerful and effective system.
Detailed Description of the Inventive Concept
The inventive concept comprises an oral dissolvable film containing vitamin D3, which is integrated with an AI-powered dosage control module that adjusts the film's composition based on a user's specific health profile and environmental conditions. Additionally, the system includes a wearable IoT device for tracking vitamin D3 levels, a blockchain-based platform for secure tracking and authentication, a novel material composition for enhanced stability and bioavailability, and a smart packaging system for monitoring environmental conditions.
Novelty and Inventive Step
The new claims introduce the novel combination of oral dissolvable films with AI, IoT, blockchain, and novel materials, which provides a non-obvious solution to the limitations of the original patent. The inventive concept's synergistic integration of these technologies creates a new, more powerful system that is not anticipated by the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms, various IoT devices, or alternative blockchain platforms. Additionally, the novel material composition could be modified to accommodate different active ingredients or delivery systems.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the healthcare and nutrition industries, particularly in the areas of personalized medicine, preventive care, and wellness. The market for vitamin D3 supplements is growing rapidly, and the inventive concept's advanced features and benefits could capture a significant share of this market.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical drug delivery systems, specifically oral dissolvable film (ODF) technologies for vitamin and nutritional supplements, requiring expertise in pharmaceutical formulation, materials science, and drug delivery mechanisms
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences or bioengineering, familiar with drug delivery technologies, polymer chemistry, and medical device design, with knowledge of emerging technologies in personalized medicine
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies with pharmaceutical delivery systems is a natural progression in personalized medicine. The combination of AI, IoT, and blockchain with existing oral dissolvable film technology represents predictable extensions of known pharmaceutical tracking and personalization techniques. The novel material compositions and smart packaging are logical improvements to address stability and bioavailability challenges inherent in vitamin D3 delivery.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,557 |
|---|---|
| Title | Oral dissolvable film containing vitamin D3 |